The Efficacy of Adjuvant Chemotherapy With Capecitabine (Xeloda) Monotherapy in Patients With Colon Cancer Stage III (Duke C) Considering the Histopathology of the Tumour (AXEL)
Phase of Trial: Phase IV
Latest Information Update: 09 Jul 2016
At a glance
- Drugs Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms AXEL
- Sponsors Roche
- 01 Jul 2016 Status changed from active, no longer recruiting to discontinued.
- 31 Jul 2015 Planned End Date changed from 1 Jun 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 31 Jul 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.